Radek
Kaczmarek/LinkedIn; Clive Smith/The Haemophilia Society
Aug 10, 2025, 06:59
WFH Throwback: WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines
World Federation of Hemophilia (WFH) recently shared on LinkedIn:
”Today, the WFH is participating in the WHO 25th Expert Committee Meeting on Selection and Use of Essential Medicines (EML).
Radek Kaczmarek, WFH CPSSA Committee Chair, and Clive Smith, WFH Volunteer and President of The Haemophilia Society, delivered a statement outlining critical updates needed to better align the EML with international clinical guidelines for hemophilia and von Willebrand Disease.”
Find the Statement and Call-to-Action presented at WHO Meeting by WFH, ISTH, EAHAD here.
The statement is also endorsed by the following organizations:
- American Society of Gene & Cell Therapy
- Asian-Pacific Society on Thrombosis and Hemostasis
- Association for Haemophilia and Allied Disorders-Asia Pacific
- European Haemophilia Consortium
- European Society for Gene and Cell Therapy
- Grupo Collectivo Latinoamericano de Hemostasis y Trombosis
- National Bleeding Disorders Foundation

Stay informed on the emerging in the field of bleeding disorders with Hemostasis Today.
-
Nov 19, 2025, 18:03Andres Ricaurte Fajardo on a Strongyloides Stercoralis Hyperinfection with Thrombosis
-
Nov 19, 2025, 17:50Marilena Vrana Reflects on PPTA Europe’s Visits with Members and Stakeholders in 2025
-
Nov 19, 2025, 17:32Michael Makris Shares Insights from Global Forum Meeting of the WFH Meeting in Montreal
-
Nov 19, 2025, 17:14Yazan Abou Ismail Takes The Legacy Award from Qatar Foundation
-
Nov 19, 2025, 17:02Wolfgang Miesbach Shares Real-World Evidence on Eptacog Beta from Spain
-
Nov 19, 2025, 16:34Ishita Singh Reflects on Haematocon 2025: A Reminder of Her Commitment to The Journey
-
Nov 19, 2025, 16:23Mehdi Kashani: I’m Really Excited to Share Schistosite.com
-
Nov 19, 2025, 16:09A ”Meow-cyte” from Melaku Abay Muluneh or Why Microscopy Never Gets Old!
-
Nov 19, 2025, 15:56Cuilan Li on her Contribution to a Cutting-Edge Project in Polycythemia Vera
